Advertisement
Lyra Therapeutics Reports Positive Topline Results From BEACON Phase 2 Study Of LYR-220
(RTTNews) - Biotechnology company Lyra Therapeutics, Inc. (LYRA) announced Tuesday positive topline results from the BEACON Phase 2 clinical study of LYR-220 in adult patients with CRS, with and without polyps, who have had prior ethmoid sinus surgery.
The study met its primary safety endpoint, with no serious adverse events observed. Most commonly reported adverse events included sinusitis, nasopharyngitis, bronchitis, and COVID-19.
LYR-220 is a bioresorbable nasal matrix designed to deliver six months of continuous anti-inflammatory medication (mometasone furoate; MF) to the sinonasal passages for the treatment of CRS.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Asian Shares Mixed As Investors Await US Inflation Data
Asian stocks turned in a mixed performance on Tuesday, with Japanese markets outperforming on tariff and earnings optimism.
RTTNews
|
6 minutos atrás
NZ Dollar Slides Against Most Majors
The New Zealand dollar weakened against other major currencies in the Asian session on Tuesday.
RTTNews
|
49 minutos atrás
Australian Dollar Falls Against Majors
The Australian dollar weakened against other major currencies in the Asian session on Tuesday.
RTTNews
|
2 h 5 min atrás
European Shares Seen Opening Up On US-China Trade Truce
European stocks may open higher on Tuesday as the United States and China agreed to extend their tariff truce for another 90 days.
RTTNews
|
3 h 14 min atrás
European Economic News Preview: UK Unemployment Data Due
Unemployment from the UK and economic confidence from Germany are the top economic news due on Tuesday. At 2.00 am ET, the Office for National Statistics publishes UK unemployment data. The jobless rate is forecast to remain unchanged at 4.7 percent in the second quarter. At 3.00 am ET, retail sales figures are due from Turkey.
RTTNews
|
3 h 29 min atrás
Sensex, Nifty Slightly Higher In Early Trade
Indian shares were slightly higher on Tuesday despite mixed cues from global markets.
RTTNews
|
4 h 18 min atrás
Australian Market Trims Early Gains In Mid-market
The Australian stock market is trimming its early gains in mid-market trading on Tuesday, but extending the gains in the previous session, despite the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,850 level to fresh all-time high, with gains in financial and energy stocks partially offset by weakness in mining and technology stocks.
RTTNews
|
5 h 5 min atrás
Asian Markets Trade Mostly Higher
Asian stock markets are trading mostly higher on Tuesday, despite the broadly negative cues from Wall Street overnight, with the Australian and the Japanese markets hitting record all-time highs, as the U.S. and China agreed to extend their tariff truce for another 90 days. Optimism about the US Fed cutting interest rate at its next meeting is also aiding market sentiment.
RTTNews
|
5 h 44 min atrás
